Back
Societe Generale SA Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
58
SCGLY
Societe Generale SA
Last Price:
5.13
Seasonality Move:
2.54%
Sell
44
MIRM
Mirum Pharmaceuticals
Last Price:
39.35
Seasonality Move:
5.99%
Buy
58
Societe Generale SA (SCGLY)
is a Buy
Is Societe Generale SA a Buy, Sell or Hold?
- The current Societe Generale SA [SCGLY] share price is $5.13. The Score for SCGLY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- SCGLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $39.34. The Score for MIRM is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- MIRM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCGLY Stock Price Chart
What is Societe Generale SA's stock price today?
-
The Societe Generale SA share price today is $5.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCGLY is experiencing slight buying pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $39.34
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight buying pressure.
SCGLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 65.23 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.73 - 4.99) | Buy |
| Bollinger Bands (100): | (4.7 - 5.6) | Sell |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 44.04 | Sell |
| Chaikin Money Flow: | 27576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.13 - 42.69) | Sell |
| Bollinger Bands (100): | (27.3 - 41.42) | Buy |
SCGLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5 | Buy |
| 20-day SMA: | 4.9 | Buy |
| 50-day SMA: | 4.9 | Buy |
| 200-day SMA: | 5.17 | Sell |
| 8-day EMA: | 5.02 | Buy |
| 20-day EMA: | 4.93 | Buy |
| 50-day EMA: | 4.93 | Buy |
| 200-day EMA: | 5.1 | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.48 | Sell |
| 20-day SMA: | 41.45 | Sell |
| 50-day SMA: | 40.72 | Sell |
| 200-day SMA: | 31.06 | Buy |
| 8-day EMA: | 40.12 | Sell |
| 20-day EMA: | 40.8 | Sell |
| 50-day EMA: | 39.41 | Sell |
| 200-day EMA: | 32.87 | Buy |
Societe Generale SA Earnings Growth & SCGLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.99 per share, and an increase next year of $0.58 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.
Societe Generale SA Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||